POPULARITY
Categories
Are you trying to figure out how to price your services? You're not alone. Most NPs get stuck here, paralyzed by what the competition is doing.In this episode, Justin talks with Laquisha Stahl, a nephrology NP who just launched her own functional medicine practice. She's navigating the same questions you are: Should you list prices on your website? How do you attract patients without a huge marketing budget? How do you balance a full-time job while building your own business?They cut through the noise and discuss real-world strategies for setting prices, acquiring your first patients, and building a practice on the side without burning out. Justin breaks down why you shouldn't get hung up on web traffic numbers and how to build a client base organically.If you're ready to launch a wellness, HRT, or functional medicine practice, this episode provides the practical, no-nonsense roadmap to get started.
Darshali Vyas is a pulmonary and critical care fellow at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.A. Vyas, L.G. Eisenstein, and D.S. Jones. The Race-Correction Debates — Progress, Tensions, and Future Directions. N Engl J Med 2025;393:1029-1036.
Interviewees: Justin Bullock, MD, MPH; Cary Payne, MD Interviewer: Lisa Meeks, PhD, MA Description: In Episode 114, Dr. Lisa Meeks talks with Dr. Justin Bullock (nephrology fellow, University of Washington; living with bipolar disorder) and Dr. Cary Payne (Program Director, Nephrology Fellowship, University of Washington) about navigating fellowship with a psychiatric disability—and how trust, humility, and creative flexibility built a training experience defined by healing and growth. Together, they retrace Justin's decision to pursue fellowship after a traumatic residency, his choice to lead with authenticity during the match, and the risks and rewards of disclosure in GME. They unpack how structured accommodations provided protection, why early defensiveness softened into trust, and the profound impact of Cary's disarming leadership approach: “It's not your job to teach us.” Listeners will hear advice for residents and fellows (consider strategic disclosure, seek accommodations as protective, build trusted provider teams) and for program directors (lead with humility, embrace uncertainty, and center accommodations in creativity rather than dogma). At its heart, the episode explores how one program became not just a safe space, but a place of healing—and why that benefits trainees, programs, and patients alike. This episode accompanies the open-access perspective This Armor of Mine: Perspectives of a Bipolar Physician and Program Director (Bullock & Payne, Chest, 2024) This episode is part of the ACGME/DWDI Disability Resource Hub, supported by the Josiah Macy Jr. Foundation Catalyst Award, it's a powerful reminder that access isn't accidental—it's built intentionally, one relationship at a time. Transcript: https://docs.google.com/document/d/1R_FlMU-qOOVKPiaBMLc0VqQ3DVX8rjhQ16ZAZZnv_TM/edit?usp=sharing Bios: Justin Bullock, MD, MPH Justin Bullock is an Assistant Professor in Nephrology at the University of Washington School of Medicine and the Co-director of the Docs with Disabilities Initiative. Justin is passionate about creating safe environments in medicine where everyone in the hospital is able to bring their authentic selves to work in the spirit of healing. Justin is a passionate medical educator: a teacher, researcher, and lifelong learner. His primary research focus centers on how educators can foster identity safety in the learning environment, where all members of the healthcare team can be their authentic selves in the workplace. When not at work, Justin enjoys running and cooking with his partner. Cary Payne, MD Cary grew up in the Pacific Northwest. He studied Biology and Philosophy at Washington University in St Louis before attending medical school at the University of Chicago. He then returned to the northwest where he completed his residency in internal medicine and fellowship in nephrology at the University of Washington, after which he remained on faculty at UW and established the UW Kidney-Liver Program, a subspecialty nephrology service dedicated to caring for patients with concomitant liver and kidney disease. In addition to his clinical work, Cary serves as the medical director for inpatient dialysis at the University of Washington and the UW Nephrology Fellowship Program Director. When not at work he enjoys reading and hiking with his wife Gretchen and his three children. Key Words: · Disability Inclusion · Residency · Fellowship · Accommodations · Program Directors · Graduate Medical Education (GME) Produced by: Lisa Meeks Resources: Article: Perspective of a Bipolar Physician and this program director. https://www.chestnet.org/guidelines-and-topic-collections/publications/chest-advocates/this-armor-of-mine Disability Resource Hub: https://dl.acgme.org/pages/disability-resource-hub Case Studies in Disability Resource Hub: https://dl.acgme.org/pages/disability-resource-hub#case_studies UME to GME Toolkit: https://dl.acgme.org/pages/disability-resource-hub-transitions-toolkit-introduction Policy Toolkit: https://dl.acgme.org/pages/disability-resource-hub-policy-toolkit Disability in Graduate Medical Education Program: https://www.docswithdisabilities.org/digme
In this first episode, host Srinath Yadlapalli, MD, speaks with Jeffrey Silberzweig, MD, and Sarrah Johnson, MSN, RN, about emergency preparedness and response in kidney care during the COVID-19 pandemic.
In this first episode, host Srinath Yadlapalli, MD, speaks with Jeffrey Silberzweig, MD, and Sarrah Johnson, MSN, RN, about emergency preparedness and response in kidney care during the COVID-19 pandemic.
In the latest episode of the Global Kidney Care Podcast, host Winston Fung speaks to Luis Gustavo Modelli de Andrade, a Nephrologist at the Kidney Transplant Program, Hospital das Clínicas da UNESP – Botucatu in Brazil. They discuss the frontiers of artificial intelligence and its applications in medicine. Dr. Gustavo discusses artificial intelligence, machine learning, and advanced modeling techniques such as deep learning. His work is focused on applying these technologies to nephrology and organ transplantation, helping to shape the future of patient care and medical innovation.
Jonathan Barratt, PhD, FRCP - The Nephrology Journal Club: B-Cell Modulators and eGFR Endpoints in IgA Nephropathy
Jonathan Barratt, PhD, FRCP - The Nephrology Journal Club: B-Cell Modulators and eGFR Endpoints in IgA Nephropathy
Jonathan Barratt, PhD, FRCP - The Nephrology Journal Club: B-Cell Modulators and eGFR Endpoints in IgA Nephropathy
Jonathan Barratt, PhD, FRCP - The Nephrology Journal Club: B-Cell Modulators and eGFR Endpoints in IgA Nephropathy
Send us a textIn this episode of The Incubator Podcast, we sit down with Dr. David Askenazi, Dr. Heidi Steflik, and Dr. Kimmy Vuong to explore the latest research and practice shifts in neonatal nephrology. The discussion begins with the often-overlooked role of the kidney in the NICU and why kidney health has direct implications for outcomes far beyond discharge.The group reviews three recent high-impact papers. The first, a secondary analysis of the PENUT trial, examines whether PDA treatment in extremely low gestational age infants influences two-year kidney outcomes, raising questions about long-term renal risks and benefits of medical and surgical interventions. The second paper presents a consensus statement on kidney health monitoring for NICU graduates, offering structured recommendations on risk stratification and follow-up for preterm, critically ill, and cardiac infants. Finally, we highlight a quality improvement initiative that used the “Can You PLOTS” bundle to reduce ventilator days by addressing fluid overload systematically, underscoring the importance of early, proactive kidney-focused care.This conversation emphasizes kidney disease as a critical factor in neonatal medicine, the growing pathways for neonatal nephrology training, and practical steps teams can take now to better integrate kidney health into NICU care.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!
Send us a textAssociation of patent ductus arteriosus treatment in extremely low gestational age neonates with two year kidney outcomes: a secondary analysis of the preterm erythropoietin neuroprotection trial (PENUT).Condit PE, Guillet R, Kaluarachchi D, Griffin RL, Menon S, Askenazi DJ, Harer MW.BMC Nephrol. 2025 Mar 19;26(1):138. doi: 10.1186/s12882-025-04065-8.PMID: 40108500 Free PMC article. Clinical Trial.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!
Send us a textKidney Health Monitoring in Neonatal Intensive Care Unit Graduates: A Modified Delphi Consensus Statement.Starr MC, Harer MW, Steflik HJ, Gorga S, Ambalavanan N, Beck TM, Chaudhry PM, Chmielewski JL, Defreitas MJ, Fuhrman DY, Hanna M, Joseph C, Kwiatkowski DM, Krawczeski CD, Liberio BM, Menon S, Mohamed TH, Rumpel JA, Sanderson KR, Schuh MP, Segar JL, Slagle CL, Soranno DE, Vuong KT, Charlton JR, Gist KM, Askenazi DJ, Selewski DT; Neonatal Kidney Health Consensus Workshop.JAMA Netw Open. 2024 Sep 3;7(9):e2435043. doi: 10.1001/jamanetworkopen.2024.35043.PMID: 39269711 Free article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!
Send us a textReducing NICU ventilator days by preventing fluid overload with the CAN-U-P-LOTS standardized bundle.Askenazi DJ, Gordon L, Griffin R, Collins M, Black A, Ambalavanan N, Webb T, Mathis M, Short K, Umberger A, Travers C.Pediatr Res. 2025 Jul 11. doi: 10.1038/s41390-025-04078-x. Online ahead of print.PMID: 40646283Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!
This summer, join host David Mandell as he revisits and highlights episodes from Season 3 and 4 of The Wealth Planning for the Modern Physician podcast, in our 2025 Summer Rewind Series. "I genuinely believe there is a lot of information to gain from all of our episodes deliver, but for the summer, I've handpicked a few that offer intriguing ideas and a unique perspective for physicians in 2025," says David. "I hope you enjoy this Season encore series. Have a great summer!" Episode 3.13 | Originally Released: March 9, 2023 In this episode, Dr. Shaminder (Shammi) Gupta joins David to discuss his career path, the impact of Hurricane Katrina on that path, and what he is learning from being a business executive as well as a clinician. Shammi begins with his background – where he grew up, what got him interested in medicine why he gravitated to internal medicine & nephrology. He explains why his first job out of training was not a fit for him and how hurricane Katrina changed his path completely – as it did for many living in New Orleans at the time – opening up a career path he would not have considered otherwise. Shammi also covers how he built a significant dialysis practice in a smaller town setting, became president of the Kidney Foundation, and built a reputation throughout the state. This led to his practice being acquired by Monogram Health, where he works today as an executive and clinician. Shammi then shares what he is learning from the “business side” of medicine, as he builds out a multi-state medical platform for kidney health, and describes the value CEOs see in physicians who can communicate well and know their field of medicine intimately. Next, David gets Shammi's insights on wealth management, including building the right advisor team and why to potentially change advisors as you grow, and Shammi concludes with his three pieces of advice for fellow physicians, especially those starting out. Learn more about our guest, including additional show notes and more, by visiting www.physicianswealthpodcast.com.
Host Matt Fisher talks to Heather Trafton, President, Evergreen Nephrology, about the evolution of value based care and building infrastructure for success; important role of data for VBC success; differences between VBC focused on primary care and specialty; lessons learned from developing new VBC approaches. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
Andrew J. Cohen, MD, FASN, leads the discussion on McCarthyism and the consequences that doctors leading the field of nephrology faced for their political ties and activism. Guests: Merlin Chowkwanyun, PhD, MPH, Kevin Lemley, MD, PhD, and Leon Fine, MD.
Andrew J. Cohen, MD, FASN, leads the discussion on McCarthyism and the consequences that doctors leading the field of nephrology faced for their political ties and activism. Guests: Merlin Chowkwanyun, PhD, MPH, Kevin Lemley, MD, PhD, and Leon Fine, MD.
Here is a classic Curbsiders episode with one of our favourite guests of all time, Dr Joel Topf. Learn how to manage diabetes and hypertension in chronic kidney disease with expert tips from Kidney Boy, Kashlak's Chief of Nephrology, Dr. Joef Topf @kidney_boy. Claim CME for this episode at curbsiders.vcuhealth.org! Heart of Care If you care about patient safety, team performance, and building a culture of readiness, subscribe to In the Heart of Care. Available now, wherever you get your podcasts. Quince Go to Quince.com/curb for free shipping on your order and three hundred and sixty-five -day returns.
Send us a textPerinatal Urinary Tract Dilation: Recommendations on Pre-/Postnatal Imaging, Prophylactic Antibiotics, and Follow-up: Clinical Report.Anthony Herndon CD, Otero HJ, Hains D, Sweeney RM, Lockwood GM; Section on Urology; Section on Nephrology; Section on Radiology; Section on Hospital Medicine.Pediatrics. 2025 Jul 1;156(1):e2025071814. doi: 10.1542/peds.2025-071814.PMID: 40518141 Review.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!
In the second part of a two-episode series on chronic kidney disease (CKD), Dr Hannah Rosa is joined again by Dr Will Hinchliffe, a Consultant in Renal and General Medicine working in the North East and North Cumbria. They discuss the management options for CKD that can be initiated in primary care. They first look at how to empower patients with lifestyle and dietary advice, then the medical treatment options we have for CKD and when to start them, before finishing with holistic care, especially with regards to cardiovascular disease. This episode is mainly based on the NICE assessment and management guideline for CKD, but it also draws on other recent guidelines from Kidney Disease Improving Global Outcomes (KDIGO) and the International Society of Nephrology as it aims to help you to improve the lives of your patients with CKD.Access episode show notes containing key references and take-home points at:https://gpnotebook.com/en-GB/podcasts/renal-medicine/ep-165-chronic-kidney-disease-among-adults-in-primary-care-testing-diagnosis-and-referral.Did you know? With GPnotebook Pro, you can earn CPD credits by tracking the podcast episodes you listen to. Learn more.
Send us a textPolycystic kidney disease (PKD) is the most common inherited kidney disease. Those with PKD have a 50% chance to pass it on to their children and have progressively worse kidney function as they age. World-known PKD researcher Dr. Fouad Chebib joins Dr. Michael Koren to discuss the symptoms, risks, genetic cause, and treatment options for PKD. They also get into some new treatement methods being explored in clinical trials and what the future of PKD treatment may look like.Dr. Chebib leads the Polycystic Kidney Disease Foundation Center of Excellence and the Discovery and Translational PKD Research Laboratory at the Mayo Clinic, Florida.The Mayo Clinical Polycystic Kidney Disease (PKD) Resource Center includes many article by Dr. Chebib himself.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!
Clement Manyathela speaks to Malcolm Davies, the Deputy Chair of the National Kidney Foundation of South Africa and Professor of Nephrology at Wits University about how best to care for your kidneys.The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.
The latest episode of the Kidney Care Podcast is a Conversation with Peter Kotanko, a leading expert on artificial intelligence applications for kidney care and the Emeritus Director of the Renal Research Institute in New York, USA. This conversation on the intersection of AI and Nephrology is the first installment in a series of conversations on AI and is part of the new ISN Academy AI resource section on the ISN Academy. This resource page will be updated regularly, providing the latest original and curated material on AI and Nephrology.
Understanding Type 2 Diabetes (Type 2 Diabetes Mellitus), including Type 2 Diabetes Pathophysiology, normal glucose homeostasis, Type 2 Diabetes symptoms as well as complications. We also cover Type 2 Diabetes diagnostic criteria as well as treatment. Consider subscribing on YouTube (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Type 2 Diabetes? 0:30 Normal Glucose Homeostasis3:02 Type 2 Diabetes Pathophysiology5:37 Type 2 Diabetes Symptoms9:12 Type 2 Diabetes Epidemiology10:17 Type 2 Diabetes Diagnosis11:43 Type 2 Diabetes Treatment / Management LINK TO MNEMONICS:https://www.youtube.com/watch?v=p-XE7PiwGgE&list=PLGNSE_HvIV4t7a33bbHN1fq-j_tge0GmpLINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesLean, M.E.J., Leslie, W.S., Barnes, A.C., et al., 2018. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet, 391(10120), pp.541–551. https://doi.org/10.1016/S0140-6736(17)33102-1MSD Manuals, n.d. Diabetes Mellitus (DM) – Endocrine and Metabolic Disorders. MSD Manual Professional Edition. Available at: https://www.msdmanuals.com/professional/endocrine-and-metabolic-disorders/diabetes-mellitus-and-disorders-of-carbohydrate-metabolism/diabetes-mellitus-dmMogensen, C.E., et al., 2016. Glucose handling by the kidney in health and disease: review of recent findings. Current Opinion in Nephrology and Hypertension, 25(4), pp.292–296. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952418/Drugs.com, 2023. What is A1C? Normal vs dangerous levels, and how to lower it. Available at: https://www.drugs.com/medical-answers/what-a1c-normal-dangerous-levels-how-lower-3579748/Please remember this podcast and all content from Rhesus Medicine is meant for educational purposes only and should not be used as a guide to diagnose or to treat. Please consult a healthcare professional for medical advice. #medicalmnemonic #medicalmnemonics #rhesusmedicine #studymedicine #studygram #medstudent #medicalschool
Welcome to the 28th episode of The Brain Podcast - the official podcast of the journals Brain and Brain Communications. This episode features a discussion with three authors of the Brain article entitled: The relationship between kidney health and neurodegenerative diseases Ms Melody Zuo, Dr Le Chang and Professor Sarah A Gagliano Taliun grace the Brain podcast with an insightful discussion into their recent review examining the connection between kidney disease and neurogeneration. They describe the critical microvascular connection as well as the role of uraemia and small molecules like erythropoetin. Additonally, methodological issues around survival bias, the use of mendelian randomisation and the importance of metadata in the growing age of large available datasets. Check out the full article on the Brain website and will be part of the August 2025 issue: https://doi.org/10.1093/brain/awaf113 This episode was co-hosted, edited and produced by Chaitra Sathyaprakash and Andreas Thermistocleous, edited and produced by Chaitra and Xin You Tai, co-produced by Antonia Johnston, original music by Ammar Al-Chalabi.
Some topics in pediatrics are flashy — like seizures, mystery rashes and fevers. While those often make headlines, others, like pediatric nephrology, are a routine but critical part of daily practice. Understanding these bread-and-butter issues is essential to diagnosing so many patients. Protein in the urine, blood pressure creeping up or a UTI that is more than ‘just a UTI' are often signs that something may be wrong with the kidneys. In this episode, we examine those practical essentials and learn how PCPs can feel confident in managing these diagnoses. This episode was recorded on the exhibit floor of the 2025 Pediatric Academic Societies Conference in Honolulu, Hawaii. Joining us for this episode are Bradley Warady, MD, and Nathan Bines, MD, both from Children's Mercy Kansas City and the University of Missouri-Kansas City School of Medicine. Dr. Warady is the Director of the Division of Nephrology, a Professor of Pediatrics and the McLaughlin Family Endowed Chair in Nephrology. Dr. Beins is the Associate Program Director for the Pediatric Nephrology Fellowship Training Program, as well as a Clinical Associate Professor of Pediatrics. Some highlights from this episode include: Understanding the core kidney issues in general pediatrics How to identify these conditions early The difference between benign findings and red flags Tools for friendly language about topics that might be sensitive or embarrassing for a child For more information on Children's Colorado, visit: childrenscolorado.org.
CME credits: 1.00 Valid until: 20-06-2026 Claim your CME credit at https://reachmd.com/programs/cme/expert-perspectives-on-nonsteroidal-mras-and-cardiorenal-protection/32990/ Heart failure with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF) represent a significant and growing burden for patients and the healthcare system, not only in cardiovascular medicine, but also in the context of cardio-kidney-metabolic (CKM) syndrome. Trials are underway evaluating new therapies that may offer benefits to patients with HFmrEF/HFpEF and may also have broader, multisystem effects. Tune in to stay up to date! =
Potassium is an essential mineral, but it is important to make sure you have the right amount. Tune in and hear from experts on how high potassium (hyperkalemia) can impact health and it's risk in people with advanced chronic kidney disease. In this episode we heard from: Briana Douglas is currently a Peer Mentor for the National Kidney Foundation. At 17 yrs old, she was diagnosed with Lupus Nephritis. She was then diagnosed with end stage 5 kidney disease, in 2016, and immediately had to start dialysis. After starting hemo dialysis, she remained on treatment for 7 years, experiencing home hemo, peritoneal, nocturnal and in center-hemo dialysis. In 2024, she received a kidney transplant and is now living really well with her new transplant. She also takes pride in being a peer Mentor for NKF to help others with similar experiences. Dr. Pascale Khairallah, MD, MS, is an Assistant Professor of Medicine in the Division of Nephrology at the University of California, San Francisco (UCSF). She specializes in chronic kidney disease and kidney transplantation. Dr. Khairallah has been recognized with multiple awards for excellence in patient care and teaching. She has multiple publications in the field of chronic kidney disease mineral and bone disorders and kidney transplant outcomes. Annabel Biruete is an Assistant Professor and Registered Dietitian in the Department of Nutrition Science at Purdue University and an Affiliate in the Division of Nephrology at the Indiana University School of Medicine. Her broad clinical interest is nutrition in kidney diseases. Her research aims to study the effects of nutritional and pharmacological therapies for chronic kidney disease on the gastrointestinal tract and gut microbiome. Additionally, she is interested in improving outcomes in the Hispanic/Latine community living with chronic kidney disease, primarily through language- and culturally-concordant interventions. Additional Resources: High Potassium Information Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.
CME credits: 0.25 Valid until: 06-06-2026 Claim your CME credit at https://reachmd.com/programs/cme/nonsteroidal-mra-sglt2i-in-people-with-ckd-t2d-current-evidence-and-rationale-for-combination-therapy/29909/ Can combining a nonsteroidal MRA and an SGLT2 inhibitor unlock new clinical potential for patients with type 2 diabetes and chronic kidney disease (CKD)? In this expert discussion, Dr. Jennifer Green and Dr. Hiddo Heerspink review the latest findings from the CONFIDENCE trial, which demonstrated a significant additive reduction in albuminuria—an important surrogate marker for kidney and cardiovascular risk—when finerenone and empagliflozin are used together. They explore the clinical rationale behind combination therapy, address persistent challenges in CKD detection, and consider the practical implications for implementing these therapies in high-risk populations.=
This special episode's participants are Winston Fung, Clinical Assistant Professor/ Associate Consultant, Division of Nephrology at the Prince of Wales Hospital, The Chinese University of Hong Kong; Isabelle Ethier, Nephrologist, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Canada and Caroline Stigant, Assistant Professor of Medicine, Division of Nephrology, University of British Columbia. This is the first of a multi-part ELP-GreenK series and part one we discuss the environmental impact of kidney care and what we can do about it! This episode is also part of the larger ISN GREEN-K initiative – Global Environmental Evolution in Nephrology and Kidney Care Curriculum on the ISN Academy. Visit to delve deeper into environmentally sustainable kidney care, all in the name of caring for our patients and the environment!
CME credits: 0.25 Valid until: 02-06-2026 Claim your CME credit at https://reachmd.com/programs/cme/fsgs-in-practice-patient-centered-decision-making/35713/ Focal segmental glomerulosclerosis (FSGS) is a prominent cause of kidney failure globally, necessitating dialysis for patient survival as the disease progresses. However, the current absence of FDA-approved treatments tailored specifically for treating adult and pediatric patients with FSGS poses a significant challenge to effectively managing this disease. Moreover, it is imperative for nephrologists to enhance their skills to implement practical strategies that improve the diagnostic approach for suspected FSGS cases, especially considering the profound impact of FSGS on patients' quality of life. This activity has been designed to provide practical guidance for the accurate diagnosis of FSGS and appropriate treatment selection, as well as to offer an expert assessment of the clinical trial data supporting emerging therapies in this setting. =
CME credits: 0.75 Valid until: 08-05-2026 Claim your CME credit at https://reachmd.com/programs/cme/insights-from-experts-preventing-and-managing-cmv-post-solid-organ-transplant/32966/ Join experts, Fernanda P. Silveira, MD, MS, FIDSA, FAST and Jennifer Saullo, MD, PharmD, FIDSA, as they delve into the complexities of cytomegalovirus (CMV) prevention and treatment following solid organ transplantation (SOT). Presentations will feature detailed case discussions with a focus on managing resistant and refractory disease, addressing treatment-related toxicities, and optimizing therapeutic strategies. This program is an essential primer on the scientific challenges and solutions in this critical area of transplant medicine. =
Dr. Benjamin HippenMD Fellowship, Heersink School of Medicine, 2004Global Head of Clinical Affairs/CMO for Care Delivery, Fresenius Medical CareMore InformationFresenius Medical Care - Dr. Hippen on the Finalization of the Improving Organ Transplant Access (IOTA) RuleFresenius Medical Care - Dr. Hippen on the Improving Organ Transplant Access RuleFresenius Medical Care - Obesity Trends, Anti-Obesity Drugs, and the Future of CKD Care
In this Nephrology episode, Dr.Samira Farouk discusses the nuances of AKI, why you should be trending Urine like you trend Troponin. Stay tuned to find out the final diagnosis! Session facilitator: Dr.Elena Storz Case Discussants: Dr.Douglas Farrell MD: Nephrology Fellow, Icahn School of Medicine at Mount Sinai Dr. Samira Farouk MD: Associate Professor of Medicine… Read More »Episode 389: Rafael Medina Subspecialty Series – Hypotension and Peaked T waves
Cody Kubiak's story is one of extraordinary resilience, faith, and hope. In this episode, we dive into his powerful journey—from childhood surgeries to receiving a kidney transplant and battling cancer. Through every trial, Cody has shown what it means to persevere and live with purpose. Hear firsthand how he turned hardship into hope, and discover why raising awareness for kidney donation is more important than ever. Dive deeper into Cody's story at kidneysquitwedont.com For more information on Kidney Solutions and to join our supportive community, visit kidneysolutions.org Host: Kent Bressler Producer: Jason Nunez Remember to keep breathing, and don't miss the next amazing episodes of Kent's Kidney Stories!
Les bananes sont une excellente source de nutriments, notamment de potassium, de fibres et de vitamines, mais une consommation excessive peut provoquer divers effets secondaires.1. Déséquilibres nutritionnelsManger trop de bananes peut entraîner un excès de certains nutriments tout en créant des carences. Les bananes sont riches en glucides, notamment en sucres naturels, mais elles manquent de protéines et de lipides. Une alimentation trop riche en bananes au détriment d'autres aliments peut déséquilibrer l'apport en macronutriments et en micronutriments essentiels, conduisant à des déficits en vitamines B12, en fer ou en acides gras essentiels.2. Effets digestifsLes bananes contiennent des fibres solubles qui aident à la digestion, mais en excès, elles peuvent provoquer des ballonnements, des gaz et même de la constipation. Paradoxalement, si elles ne sont pas assez mûres, leur teneur élevée en amidon résistant peut ralentir le transit intestinal. Inversement, des bananes très mûres peuvent avoir un effet laxatif si consommées en grande quantité.3. Hyperkaliémie et risques cardiaquesL'un des principaux risques liés à une surconsommation de bananes est l'excès de potassium, un minéral essentiel au bon fonctionnement du cœur. Une consommation excessive peut entraîner une hyperkaliémie, une condition où les niveaux de potassium dans le sang deviennent trop élevés. Cela peut provoquer des symptômes tels que des palpitations, une faiblesse musculaire, voire, dans les cas extrêmes, des arythmies cardiaques pouvant être dangereuses.Une étude publiée dans le Journal of the American Society of Nephrology (2017) montre que l'hyperkaliémie est particulièrement préoccupante pour les personnes souffrant d'insuffisance rénale. Les reins étant responsables de l'élimination du potassium, leur incapacité à le filtrer efficacement peut rendre la consommation excessive de bananes risquée pour ces individus.4. Excès de sucre et prise de poidsBien que naturelles, les bananes sont riches en glucides, avec environ 14 grammes de sucre par fruit moyen. En consommer trop peut contribuer à une augmentation de la glycémie et, à long terme, favoriser une prise de poids si elles sont consommées en excès sans équilibre avec d'autres nutriments.ConclusionSi les bananes sont un excellent aliment, elles doivent être consommées avec modération. Une alimentation variée et équilibrée reste la clé d'une bonne santé ! Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.
March is National Kidney Month. Kidneys are two bean-shaped organs that filter wastes and extra water out of our blood and make urine. Damage to your kidneys means they can't filter blood the way it should, which could lead to kidney disease. Our guest for this episode is Leo Yamaguchi, M.D., associate program director and vice chief of clinical services for the TTUHSC School of Medicine's Internal Medicine Division of Nephrology. Dr. Yamaguchi explains how our kidneys work, some of the causes of kidney disease, how we can keep our kidneys safe and why we might want to consider becoming an organ donor.
The FiltrateJoel TopfSwapnil HiremathAC GomezSopia AmbrusoNayan AroraSpecial Guests Michelle Rheault, Director, Division of Pediatric Nephrology, Professor of MedicineTiffany Caza, Nephropathologist, Scientist and self-described Freely Filtered fan girlEditing bySimon Topf and Sophia AmbrusoShow Notes10. Healthcare Cyberattacks9. ApoE in C3 glomerulonephropathy8. Workforce woes in Adult and Pediatric Nephrology7. Hyponatremia correction meta-analysis6. Microvascular inflammation increases risk of graft loss - in all of its forms5. Xenotransplantation4. KDIGO CKD Guidelines3. Hypertension control trials (ESPRIT, BPROAD)2. The Renaissance of IgAN: IgAN treatment trials1. FLOW: GLP-1 RAs in CKD
In this special World Kidney Day podcast episode, Martina Pirotta, WKD Campaign Manager on behalf of the ISN, welcomes Dr. José Moura-Neto, President of the Brazilian Society of Nephrology, and Dr. Viviane Calice Silva, Director of the Department of Epidemiology and Prevention of Kidney Diseases at the Brazilian Society of Nephrology to describe the current landscape of chronic kidney disease (CKD) in Brazil. They discuss how Brazil commemorates World Kidney Day, with over 1,000 activities taking place annually, the impact of awareness initiatives, and a significant study on CKD screening using point-of-care creatinine testing across the country.
Almost 2400 years ago, Hippocrates said "All disease begins in the gut"; and he was right. With modern scientific methods and studies to prove it, we can see exactly how and why all dieases begin in your gut, and what you can do to stop them. 93% od the leading causes of death are connected to your gut, and this episode is going to explain why that it, how it happens and to give you the tools you need to not only protect yourself and your loved ones, but even to reverse almost any diease. TOPICS DISCUSSED: Reversing 93% of the leading causes of death The machanisms of how all diease begins in your gut How endotoxins (gut toxins) circulate around your body What they do to your organ systems and your body How to heal and seal your gut Reverse chronic inflammatory diseases How to heal from almost anything Leave us a Review: https://www.reversablepod.com/review Need help with your gut? Click the link, or visit gutsolution.ca for help: Get help now Supplements: Get 15% off Practitioner Grade Supplements (forever) by creating an account Contact us: reversablepod.com/tips SOCIAL MEDIA: Instagram Facebook YouTube STUDIES FOR REFERENCE: 1. LPS and Liver Disease: · Key Study: Lipopolysaccharides promote hepatic steatosis by activating the TLR4-NF-κB pathway in hepatocytes (Cai et al., 2012, Hepatology). Link: https://pubmed.ncbi.nlm.nih.gov/22025365/ 2. LPS and Kidney Disease: · Key Study: Role of lipopolysaccharide in the pathogenesis of kidney injury in sepsis (Matsushita et al., 2021, Nephrology). Link: https://pubmed.ncbi.nlm.nih.gov/33460487/ 3. LPS and Diabetes: · Key Study: Gut-derived endotoxin and metabolic inflammation in type 2 diabetes (Cani et al., 2007, Diabetologia). Link: https://pubmed.ncbi.nlm.nih.gov/17471239/ 4. LPS and Cancer: · Key Study: Gut microbiota-mediated inflammation in obesity: A link with gastrointestinal cancer (Cani et al., 2018, Nature Reviews Gastroenterology & Hepatology). Link: https://pubmed.ncbi.nlm.nih.gov/29348450/ 5. LPS and Cerebrovascular Disease: · Key Study: LPS-induced systemic inflammation exacerbates brain damage in ischemic stroke (Chen et al., 2016, Stroke). Link: https://pubmed.ncbi.nlm.nih.gov/26846899/ 6. LPS and Parkinson's Disease: · Key Study: Lipopolysaccharide induces neuroinflammation and dopaminergic neuron loss in Parkinson's disease models (Qin et al., 2007, Journal of Neuroscience). Link: https://pubmed.ncbi.nlm.nih.gov/17360907/ 7. LPS and Hypertension: · Key Study: Role of gut-derived endotoxemia in systemic inflammation and hypertension (Tang et al., 2017, Hypertension). Link: https://pubmed.ncbi.nlm.nih.gov/28209750/ 8. LPS and Colon/Gut Diseases: · Key Study: Lipopolysaccharides promote intestinal inflammation by disrupting the epithelial barrier (Schmidt et al., 2015, Gut). Link: https://pubmed.ncbi.nlm.nih.gov/25691570/ 9. Studies Supporting LPS's Role in Alzheimer's: · Study 1: Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer's disease brain (Zhao et al., 2017, Frontiers in Immunology). Link: https://pubmed.ncbi.nlm.nih.gov/28928740/ · Study 2: Lipopolysaccharides cause neuronal death and cognitive decline (Molecules, 2022). Link: https://pubmed.ncbi.nlm.nih.gov/35011994/ · Study 3: Neuroinflammation and Alzheimer's disease: Mechanisms of action (Nature Neuroscience, 2019). Link: https://pubmed.ncbi.nlm.nih.gov/30842661/
High phosphorus (hyperphosphatemia) is a common complication caused by chronic kidney disease. Join us for this NKF Live to learn more about why this happens and how to successfully manage high phosphorus in CKD. During this program, you will hear a kidney doctor, a clinical pharmacist, and a person living with high phosphorus discuss important information to know about when managing high phosphorus. Dr. Jay Wish is Professor of Clinical Medicine at Indiana University School of Medicine in Indianapolis and Chief Medical Officer for Outpatient Dialysis at Indiana University Health. He is past president of the National Forum of ESRD Networks, served on the Board of Directors of the Renal Physicians Association and the American Association of Kidney Patients and was the recipient of the latter's Visionary Award in 2005. He has over 150 articles, reviews, and book chapters published, particularly in the areas of ESRD quality oversight/improvement, accountability, anemia management and vascular access. Dr. Katie Cardone is an associate professor at Albany College of Pharmacy and Health Sciences in Albany, NY. She is a clinical pharmacist with a clinical practice and research program focused on improving care in patients with kidney disease in outpatient nephrology and dialysis. She co-led the publication of pharmacy practice standards for pharmacists caring for people with kidney disease. She is a member of the Board of Pharmacy Specialties Ambulatory Care Pharmacy Council and is a fellow of the National Kidney Foundation, the American Society of Nephrology, and the American College of Clinical Pharmacy. Quenton Turner Gee has been on in-center hemodialysis for about 2 years. He was diagnosed with Stage 4 CKD in 2020. After a battle with COVID-19, it quickly progressed to end-stage kidney disease. Since starting on dialysis, he's been advocating for mental health and policies improving access to transplants and kidney innovations. Additional Resources: Phosphate Lowering Agents High Phosphorus Information NKF Peers Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.
2025 will bring BIG changes to the dialysis world. As of Jan 01, oral phosphorus binders will be part of the dialysis payment bundle, out-of-pocket costs for prescription medications are changing in amounts and payment models, and coverage for certain dental services is expanding, to name a few. In this episode we will explore how these changes will likely impact patients, nephrologists, and dialysis units. Thanks for joining us on this ride of the Kidney Commute! This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Nephrologist Manjula Tamura discusses the downsides of kidney dialysis, especially for old or frail patients. Her field has set its sights on offering alternatives, including supportive medical management without dialysis, dialysis in increments, wearable artificial kidneys, and transplanted kidneys from genetically modified pigs – in addition to advances in preventive care that can help humans avoid kidney failure in the first place. Dialysis can extend life, she says, but it is a lifestyle change. The goal is to ensure that every patient's choice aligns with their values and life goals, Tamura tells host Russ Altman in this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Manjula Kurella TamuraConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Manjula Tamura, a professor of medicine and nephrology at Stanford University Medical School.(00:02:58) The Kidney's Vital RoleThe kidney's role and why its failure is life-threatening.(00:04:51) Causes of Kidney FailureThe leading causes of kidney failure in developed countries.(00:07:58) Kidney TransplantationThe feasibility, barriers, and supply challenges of kidney transplantation.(00:09:50) The Dialysis ProcessHow hemodialysis and peritoneal dialysis work and patient experiences.(00:14:07) The Evolution of Dialysis TreatmentThe history of dialysis and how Medicare's expansion influenced its use.(00:18:48) Study Design: Emulating Clinical TrialsUsing VA electronic health records to simulate trials on dialysis.(00:25:31) Findings: Survival vs. Time at HomeThe trade-offs between extended survival and reduced time at home.(00:27:02) Quality of Life and DialysisMeasuring quality of life impacts through electronic health records.(00:30:32) The Future of Kidney TreatmentsInnovations like xenotransplantation and wearable artificial kidneys.(00:33:04) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook
In this episode, Alex Liang, CEO of Dallas Nephrology Associates, discusses the challenges and opportunities in nephrology, including the transition to value-based care, the impact of Medicare Advantage, and the importance of maintaining independent practices. He shares leadership insights and strategies for adapting to the rapidly evolving healthcare landscape while prioritizing patient care and organizational integrity.
Chronic kidney disease develops among 30% to 40% of people with type 1 or type 2 diabetes during their lifetime. Author Ian H. de Boer, MD, MS, of the University of Washington Division of Nephrology, discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content: Diabetes and Chronic Kidney Disease
Contributor: Alec Coston MD Educational Pearls: Causes of seizures in a fairly well-appearing child with diarrhea: Electrolyte abnormalities: hypocalcemia, hyponatremia Also hyperkalemia which causes arrhythmias and syncope - can appear like seizures Hypoglycemia If the child has diarrhea and appears very sick, differential diagnosis may include: Hemolytic uremic syndrome (HUS): simultaneous occurrence of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury Typically caused by Shiga-like toxin producing Escherichia coli (also known as EHEC, or enterohemorragic E. coli) One of the main causes of acute kidney injury in children Toxic ingestions such as salicylates, lead, or iron In this case, the child had a seizure but appeared well and was afebrile: Consult with neurology led to a diagnosis of benign convulsions with mild gastroenteritis (CwG) First identified in 1982 in Japan Viral gastroenteritis with diarrhea and convulsions but does not include fever, severe dehydration, or electrolyte abnormalities Uncommon illness caused by rotavirus and norovirus pathogens Criteria for discharge is similar to a febrile seizure - the patient had one seizure that lasted less than 15 minutes and he quickly returned to his baseline, so he was able to be safely discharged home This diagnosis does not predispose him to epilepsy later in life References Lee YS, Lee GH, Kwon YS. Update on benign convulsions with mild gastroenteritis. Clin Exp Pediatr. 2022 Oct;65(10):469-475. doi: 10.3345/cep.2021.00997. Epub 2021 Dec 27. PMID: 34961297; PMCID: PMC9561189. Mauritz M, Hirsch LJ, Camfield P, et al. Acute symptomatic seizures: an educational, evidence-based review. Epileptic Disorders. 2200;1(1). doi:https://doi.org/10.1684/epd.2021.1376 Noris, Marina*; Remuzzi, Giuseppe*, †. Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology 16(4):p 1035-1050, April 2005. | DOI: 10.1681/ASN.2004100861 Summarized by Meg Joyce, MS1 | Edited by Meg Joyce & Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/
Thanks for tuning in for a RERUN episode. Was the women's ASIFA a success? Why was it so inspiring? Why were so many many turned off? What did they do right? How could have it been better? How does Charedi leadership feel about women, their roles and right for self expression? Listen to this episode to hear a frank discussion that brings up all sides. Check out the original episode on this show with Dr. Efrat Bruck: https://podcasts.apple.com/us/podcast/lets-talk-about-the-issues-brought-up-in-my/id1316933734?i=1000529763337 Link to the latest music release "Times Of Our Lives": Kol Isha https://www.youtube.com/watch?v=LypQ6opliv4&feature=youtu.be If you'd like podcast support, please reach out to franciska@franciskakosman.com If you'd like to book a consult session with Franciska, click here: https://checkout.square.site/merchant/5BECR8D49NYV3/checkout/FVSNPB7HVW36LOYAR3L7SJMU If you'd like to sponsor an episode, click here: https://checkout.square.site/merchant/5BECR8D49NYV3/checkout/6KYMG7OGFR4Y63C43RREZ5MV Check out www.JewishCoffeeHouse.com for more Jewish Podcasts on our network. ABOUT OUR GUEST: Efrat Bruck, MD, graduated from the Icahn School of Medicine at Mount Sinai in New York City and is now an anesthesiology resident at the Mount Sinai Hospital. Before medical school, she taught Judaic studies, Hebrew, and Biology to 1000 now-alumni of Be'er Hagolah Institutes, in Brooklyn, NY. Dr. Bruck has worked as a content specialist for Khan Academy and created over 30 MCAT preparation videos on topics in molecular biology, DNA, and genetics that have also recently been translated into foreign languages. Her videos have been published on the AAMC (American Association of Medical Colleges) website, Khan Academy, and YouTube, accruing millions of views on the latter. Dr. Bruck has published research in Nature, the Journal of the American Society of Nephrology, and Obstetrics and Gynecology. Dr. Bruck founded and leads the JOWMA PreMed Society that aims to advance Jewish women, from all backgrounds, in medicine. Dr. Bruck is a fierce advocate for premed students from insular and underrepresented backgrounds and strives to provide them with the resources and tools necessary to compete. (www.jowma.org/pre-med). She was among two out of 200 graduating MDs, PhDs, and MD/PhDs at Sinai's recent commencement to be awarded the Patricia Levinson Award for the Advancement and Inclusion of Women in Medicine. Dr. Bruck, along with her colleagues at JOWMA, is also currently in the process of constructing a cultural competency curriculum that will help healthcare professionals in New York City hospitals provide culturally sensitive medical care to Jewish populations across the entire spectrum of Orthodoxy. Dr. Bruck's experiences in education, acceptance to nearly 10 US MD programs, and service on the admissions committee of the Icahn School of Medicine at Mount Sinai have led her to have a highly successful track record helping premeds navigate the medical school application process. She is the founder and CEO of MDInspire, a medical school admissions consultancy that provides professional consulting for fees that are reasonable and a fraction of the standard costs. Dr. Bruck specializes in helping people weave their stories seamlessly through their application, building stellar personal statements and activities sections, interview preparation, and coaching students on how to study smarter, not harder. For more information, please visit: www.MDInspire.com. BlogPost: http://www.rationalistjudaism.com/2021/07/from-bais-yaakov-to-md.html Instagram: drbruck_mdinspire Facebook: Efrat Bruck LinkedIn: Efrat Bruck, MD website: www.MDInspire.com YouTube: Efrat Bruck www.jowma.org/pre-med
Learn how to manage diabetes and hypertension in chronic kidney disease with expert tips from Kidney Boy, Kashlak's Chief of Nephrology, Dr. Joef Topf @kidney_boy. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Credits Written and Produced by: Fatima Syed, MD, MSc Infographic and Cover Art: Zoya Surani, MD Show Notes: Fatima Syed, MD, MSc Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Sai S Achi, MD, MBA, FACP Showrunners: Matthew Watto MD, FACP and Paul Williams MD, FACP Technical Production: Pod Paste Guest: Joel Topf, MD Sponsor: Mint Mobile To get this new customer offer and your new 3-month premium wireless plan for just 15 bucks a month, go to mintmobile.com/CURB. Sponsor: ClinicalKey AI ClinicalKey AI is an award-winning solution that combines trusted, evidence-based clinical content with conversational search powered by generative AI. To unlock the power of AI in clinical decision-making with ClinicalKey AI, visit Elsevier.health/AI” Sponsor: Freed You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month.